BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35091815)

  • 21. SATB2 is a supplementary immunohistochemical marker to CDX2 in the diagnosis of colorectal carcinoma metastasis in an unknown primary.
    Dabir PD; Svanholm H; Christiansen JJ
    APMIS; 2018 Jun; 126(6):494-500. PubMed ID: 29924451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutaneous metastases from neuroendocrine carcinoma of the cervix-An unusual metastatic lesion from an uncommon malignancy.
    Devnani B; Kumar R; Pathy S; Phulware RH; Mathur S; Kumar L
    Curr Probl Cancer; 2018 Sep; 42(5):527-533. PubMed ID: 29937242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical characterization of appendiceal mucinous neoplasms and the value of special AT-rich sequence-binding protein 2 in their distinction from primary ovarian mucinous tumours.
    Strickland S; Parra-Herran C
    Histopathology; 2016 Jun; 68(7):977-87. PubMed ID: 26542609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroendocrine Carcinoma of the Cervix: Review of a Series of Cases and Correlation With Outcome.
    Ganesan R; Hirschowitz L; Dawson P; Askew S; Pearmain P; Jones PW; Singh K; Chan KK; Moss EL
    Int J Surg Pathol; 2016 Sep; 24(6):490-6. PubMed ID: 27098591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value of SATB2 in the differential diagnosis of intestinal-type mucinous tumors of the ovary: primary vs metastatic.
    Perez Montiel D; Arispe Angulo K; Cantú-de León D; Bornstein Quevedo L; Chanona Vilchis J; Herrera Montalvo L
    Ann Diagn Pathol; 2015 Aug; 19(4):249-52. PubMed ID: 26059401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic accuracy of a panel of immunohistochemical and molecular markers to distinguish Merkel cell carcinoma from other neuroendocrine carcinomas.
    Kervarrec T; Tallet A; Miquelestorena-Standley E; Houben R; Schrama D; Gambichler T; Berthon P; Le Corre Y; Hainaut-Wierzbicka E; Aubin F; Bens G; Tabareau-Delalande F; Beneton N; Fromont G; Arbion F; Leteurtre E; Touzé A; Samimi M; Guyétant S
    Mod Pathol; 2019 Apr; 32(4):499-510. PubMed ID: 30349028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary Ovarian High-grade Neuroendocrine Carcinoma With Merkel Cell-like Immunophenotype Arising in a Teratoma.
    Harkness R; Kelly PJ; McCluggage WG
    Int J Gynecol Pathol; 2020 Sep; 39(5):478-484. PubMed ID: 31584482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mucin phenotype expression of gastric neuroendocrine neoplasms: analysis of histopathology and carcinogenesis.
    Domori K; Nishikura K; Ajioka Y; Aoyagi Y
    Gastric Cancer; 2014 Apr; 17(2):263-72. PubMed ID: 23828549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
    McCluggage WG; Kennedy K; Busam KJ
    Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poorly differentiated neuroendocrine carcinomas of the gastrointestinal tract: A single-institute study of 43 cases.
    Chen I; Zhang D; Velez M; Kovar S; Liao X
    Pathol Res Pract; 2021 Oct; 226():153614. PubMed ID: 34555651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SATB2 Expression Is Sensitive but Not Specific for Osteosarcomatous Components of Gynecologic Tract Carcinosarcomas: A Clinicopathologic Study of 60 Cases.
    Sangoi AR; Kshirsagar M; Horvai AE; Roma AA
    Int J Gynecol Pathol; 2017 Mar; 36(2):140-145. PubMed ID: 27294605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroendocrine carcinomas of the uterine cervix: A clinicopathological study.
    Sitthinamsuwan P; Angkathunyakul N; Chuangsuwanich T; Inthasorn P
    J Med Assoc Thai; 2013 Jan; 96(1):83-90. PubMed ID: 23720983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The utility of PAX8 and SATB2 immunohistochemical stains in distinguishing ovarian mucinous neoplasms from colonic and appendiceal mucinous neoplasm.
    Aldaoud N; Erashdi M; AlKhatib S; Abdo N; Al-Mohtaseb A; Graboski-Bauer A
    BMC Res Notes; 2019 Nov; 12(1):770. PubMed ID: 31771640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberrant expression of SATB2, CDX2, CDH17 and CK20 in hepatocellular carcinoma: a pathological, clinical and outcome study.
    Kmeid M; Lukose G; Hodge K; Cho D; Kim KA; Lee H
    Histopathology; 2021 Nov; 79(5):768-778. PubMed ID: 34036629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SATB2 Expression in Human Tumors: A Tissue Microarray Study on More Than 15 000 Tumors.
    Dum D; Kromm D; Lennartz M; De Wispelaere N; Büscheck F; Luebke AM; Burandt E; Menz A; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Weidemann S; Fraune C; Möller K; Lebok P; Sauter G; Simon R; Uhlig R; Wilczak W; Minner S; Krech R; Bernreuther C; Marx A; Steurer S; Jacobsen F; Clauditz T; Krech T
    Arch Pathol Lab Med; 2023 Apr; 147(4):451-464. PubMed ID: 35917493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SATB2 is a Promising Biomarker for Identifying a Colorectal Origin for Liver Metastatic Adenocarcinomas.
    Zhang YJ; Chen JW; He XS; Zhang HZ; Ling YH; Wen JH; Deng WH; Li P; Yun JP; Xie D; Cai MY
    EBioMedicine; 2018 Feb; 28():62-69. PubMed ID: 29396302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CDX2, SATB2, GATA3, TTF1, and PAX8 Immunohistochemistry in Krukenberg Tumors.
    Chiesa-Vottero A
    Int J Gynecol Pathol; 2020 Mar; 39(2):170-177. PubMed ID: 32045390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
    Tang LH; Basturk O; Sue JJ; Klimstra DS
    Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of SATB2 expression in colon cancer and its differential diagnosis in digestive tract adenocarcinoma and ovarian primary and metastatic carcinoma.
    Liu F; Gao Z; Shen D; Zhao H; Wang C; Ye Y; Ma Y; Kong F
    Pathol Res Pract; 2019 Jul; 215(7):152430. PubMed ID: 31101576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic Utility of SATB2 in Metastatic Krukenberg Tumors of the Ovary: An Immunohistochemical Study of 70 Cases With Comparison to CDX2, CK7, CK20, Chromogranin, and Synaptophysin.
    Yang C; Sun L; Zhang L; Zhou L; Zhao M; Peng Y; Niu D; Li Z; Huang X; Kang Q; Jia L; Lai J; Cao D
    Am J Surg Pathol; 2018 Feb; 42(2):160-171. PubMed ID: 28914716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.